Лекарственные препараты

ALPHARONA® (interferon alpha-2b, 50,000 IU) identical with human interferon, has immunostimulating, antiviral, antiinflammatory and antimicrobial activity and is indicated for prevention and treatment of influenza and other ARVIs, especially, at early stages of the disease. The drug is allowed both for children from the first days of life and adults. The drug is administered intranasally (nasal drops).
ALPHARONA (interferon alpha-2b, 500 000 IU, 1 000 000 IU, 3 000 000 IU, 5 000 000 IU). 
In combined therapy of adults: 
  • acute viral hepatitis В - moderate and severe forms at the beginning of icteritous period;
  • acute prolonged hepatitis В, chronic active viral hepatitis В and D, hepatitis С;
  • encephalomeningitis: viral, viral and bacterial, mycoplasmal;
  • viral conjunctivitis, keratoconjunctivitis, keratitis, keratouveitis;
  • stage IV kidney cancer, hairy-cell leukemia, malignant skin lymphadenosis, Kaposi's sarcoma, basal cell and squamous cell carcinoma of the skin, keratoacanthoma, chronic myelogenous leukemia, histiocytosis-X, subleukemic myelosis, essential thrombocytopenia;
  • disseminated sclerosis.
INGARON® (interferon gamma, 100,000 IU) identical with human interferon, has immunostimulating and antiviral activity: promotes formation of cell resistance against influenza virus. INGARON® efficiently stimulates immunity and ensures protection against influenza, including H5N1 and H1N1. The drug is administered intranasally  (nasal drops).
INGARON® (interferon gamma, 100,000 IU, 500,000 IU, 1,000,000 IU, 2,000,000 IU).

Treatment in combined therapy:

  • chronic viral hepatitis C;
  • chronic viral hepatitis В;
  • HIV/AIDS infection;
  • pulmonary tuberculosis;
  • oncologic diseases as immunomodulator, including in combination with chemotherapy;
  • urogenital clamidiosis;
  • chronic prostatitis. 
Treatment in monotherapy:
  • human papilloma virus (HPV);
  • herpes virus infection;
  • genital herpes virus infection;
  • herpes zoster;
  • anogenital warts (human papilloma virus) and prevention of disease recurrence. 
  • infectious complications in patients with chronic granulomatous disease.